Feature Channels: Drugs and Drug Abuse

Filters close
Released: 13-Apr-2021 3:30 PM EDT
Smoking cannabis significantly impairs vision, study finds
University of Granada

Smoking cannabis significantly impairs vision but many users are unaware of it

Released: 12-Apr-2021 5:05 PM EDT
Psychedelic Experience May Not be Required for Psilocybin’s Antidepressant-like Benefits, UM School of Medicine Study Shows
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) researchers have shown that psilocybin—the active chemical in “magic mushrooms”— still works its antidepressant-like actions, at least in mice, even when the psychedelic experience is blocked.

Released: 12-Apr-2021 3:05 PM EDT
Scientists Reveal COVID-19 News, Next Frontier in Fighting Substance Abuse, More
Federation of American Societies for Experimental Biology (FASEB)

Register for online access to cutting-edge science at Experimental Biology 2021, April 27–30

   
17-Mar-2021 9:00 AM EDT
Drug used during pregnancy may increase cancer risk in mother’s adult children
Endocrine Society

Exposure in the womb to a drug used to prevent miscarriage appears to raise the offspring’s cancer risk decades later, especially for colorectal and prostate cancers, researchers have found. They will present the results of their new study Tuesday at ENDO 2021, the Endocrine Society’s annual meeting.

16-Mar-2021 12:15 PM EDT
Staff Dedication Key To Patient Satisfaction with Substance Use Treatment Facilities, Study Shows
Perelman School of Medicine at the University of Pennsylvania

Researchers at Penn Medicine used machine learning-aided analysis to uncover top positive and negative themes in patient Yelp reviews of substance use treatment facilities

Released: 11-Mar-2021 1:55 PM EST
Sharp reductions in costs of producing cannabis, fentanyl likely to spur widespread changes in use, dependence
Carnegie Mellon University

The legalization of cannabis and the arrival of nonmedical fentanyl are fundamentally changing drug markets in North America.

Released: 12-Feb-2021 10:55 AM EST
Death by suicide? Drug overdoses muddy waters for investigators, amplify national mental health crisis
West Virginia University

Broadening the definition of self-inflicted mortality to encompass most drug overdose deaths, WVU emeritus professor Ian Rockett led a study finding that the entire nation is afflicted by a mental health crisis. In recent years, western states have reported more suicides but Rockett’s research revealed that many drug overdose deaths in non-western states should have been classified as suicides.

Released: 28-Jan-2021 3:20 PM EST
Legal cannabis stores linked to fewer opioid deaths in the United States
BMJ

Findings may have implications for tackling opioid misuse

Released: 27-Jan-2021 11:00 AM EST
Patients who take opioids for pain can’t get in the door at more than half of primary care clinics
Michigan Medicine - University of Michigan

People who take opioid medications for chronic pain may have a hard time finding a new primary care clinic that will take them on as a patient if they need one, according to a new “secret shopper” study of hundreds of clinics across the country.

Released: 21-Jan-2021 11:05 AM EST
Modified pain management strategy reduces opioid exposure to trauma patients, study shows
University of Texas Health Science Center at Houston

A pain management regimen comprised mostly of over-the-counter medication reduced opioid exposure in trauma patients while achieving equal levels of pain control, according to a new study by physician-researchers at UTHealth.

19-Jan-2021 3:15 PM EST
Opiate Overdoses Spike in Black Philadelphians, But Drop in White Residents Since COVID-19
Perelman School of Medicine at the University of Pennsylvania

New research into opioid overdoses that occurred during the COVID-19 pandemic highlighted new disparities along racial lines that are likely fueled by existing inequality

Released: 13-Jan-2021 5:05 PM EST
New Combination Drug Therapy Offers Hope Against Methamphetamine Addiction
UT Southwestern Medical Center

DALLAS – Jan. 13, 2021 – A new treatment that combines two existing medications may provide long-sought relief for many battling debilitating methamphetamine use disorder, according to a study to be published tomorrow in The New England Journal of Medicine.

Released: 12-Jan-2021 11:00 AM EST
Foundation for Opioid Response Efforts (FORE) Establishes Scientific Advisory Council to Advance Initiatives Addressing the Nationwide Opioid Crisis
Foundation for Opioid Response Efforts (FORE)

The Foundation for Opioid Response Efforts (FORE) today announced the establishment of its Scientific Advisory Council to provide program-related guidance to assist the Foundation in addressing the nation’s opioid crisis.

Released: 8-Jan-2021 4:45 PM EST
More than half of people using cannabis for pain experience multiple withdrawal symptoms
Michigan Medicine - University of Michigan

More than half of people who use medical marijuana products to ease pain also experience clusters of multiple withdrawal symptoms when they’re between uses, a new study finds. And about 10% of the patients taking part in the study experienced worsening changes to their sleep, mood, mental state, energy and appetite over the next two years as they continued to use cannabis.

Released: 8-Jan-2021 3:20 PM EST
News Release: S&T Seeks Industry Participation in Battle Against Opioids
Homeland Security's Science And Technology Directorate

DHS S&T is working with the Pacific Northwest National Laboratory (PNNL) on a multi-phase study to improve detection of synthetic opioids.

   
Released: 7-Jan-2021 10:05 AM EST
The Link Between Opioid Medication and Pancreatic Cancer
RUSH

Researchers at Rush University Medical Center have found that opioid use might increase a person's risk of developing pancreatic cancer.

Released: 28-Dec-2020 11:25 AM EST
One psychedelic experience may lessen trauma of racial injustice
Ohio State University

A single positive experience on a psychedelic drug may help reduce stress, depression and anxiety symptoms in Black, Indigenous and people of color whose encounters with racism have had lasting harm, a new study suggests.

Released: 21-Dec-2020 2:10 PM EST
Cannabis could reduce fentanyl use, reduce overdose risk
University of British Columbia

New research suggests that cannabis use by people in care for opioid addiction might improve their treatment outcomes and reduce their risk of being exposed to fentanyl in the contaminated unregulated drug supply.

   
Released: 21-Dec-2020 11:55 AM EST
Recommendations for the Overdose Epidemic in the COVID-19 Pandemic
Johns Hopkins Bloomberg School of Public Health

A new report from researchers at the Johns Hopkins Bloomberg School of Public Health offers recommendations aimed at federal, state, and local policymakers to address the opioid epidemic during the pandemic.

Released: 17-Dec-2020 12:50 PM EST
Pandemic has severely disrupted sleep, increasing stress and medication use
University of Ottawa

The COVID-19 pandemic is seriously affecting the sleep habits of half of those surveyed in a new study from The Royal and the University of Ottawa, leading to further stress and anxiety plus further dependence on sleep medication.

   
10-Dec-2020 10:00 AM EST
Experts to Discuss the Essential Efforts of Clinical Laboratories to Fight the Opioid Epidemic at the 2020 AACC Annual Scientific Meeting
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

The opioid epidemic has only gotten worse since the advent of COVID-19, with some areas in the U.S. reporting a 50% increase in drug overdoses due to the pandemic. With no end in sight to this public health crisis, scientific sessions during the virtual 2020 AACC Annual Scientific Meeting & Clinical Lab Expo will highlight the integral role of clinical laboratories in efforts to manage it, as well as the latest drug tests needed to do so.

Released: 7-Dec-2020 2:10 PM EST
Novel Anti-Craving Mechanism Discovered to Treat Cocaine Relapse
University of Pennsylvania School of Nursing

Cocaine continues to be one of the most commonly abused illicit drugs in the United States. Pre-clinical literature suggests that targeting glucagon-like peptide-1 receptors (GLP-1Rs) in the brain may represent a novel approach to treating cocaine use disorder. Specifically, GLP-1R agonists, which are FDA-approved for treating diabetes and obesity, have been shown to reduce voluntary drug taking and seeking in preclinical models of cocaine used disorder. However, the exact neural circuits and cell types that mediate the suppressive effects of GLP-1R agonists on cocaine-seeking behavior are mostly unknown.

Released: 3-Dec-2020 12:55 PM EST
After CDC guidance, little change in opioid prescriptions to those at risk of misuse
Saint Louis University

Research from Saint Louis University finds that among patients at risk for opioid misuse, the odds of receiving a schedule II opioid for non-cancer pain were similar to those not at risk, despite new prescribing guidelines from the Centers for Disease Control (CDC).

Released: 23-Nov-2020 11:50 AM EST
Nurse practitioners play key role in opioid addiction treatment in very rural areas
Washington State University

Giving nurse practitioners the authority to prescribe buprenorphine has brought that gold standard treatment for opioid addiction to people who might not have had access to it before, according to a new study led by Tracy Klein, PhD, associate professor at the Washington State University College of Nursing in Vancouver.

Released: 17-Nov-2020 8:45 AM EST
Cannabis strength soars over past half century -- new study
University of Bath

New research shows that over the past 50 years street cannabis across the world has become substantially stronger carrying an increased risk of harm.

Released: 10-Nov-2020 3:05 PM EST
Understanding Impacts of COVID-19 on Substance Use Disorder and Treatment
Rutgers University-New Brunswick

A Rutgers expert discusses the many impacts of COVID-19 on people with substance use disorder and what treatment providers, policymakers and researchers are doing to help.

Released: 26-Oct-2020 8:55 AM EDT
Real-time opioid overdose tracking system shows rise in the time of COVID-19
Michigan Medicine - University of Michigan

An epidemic that was already raging before COVID-19 arrived has flared up in recent months, according to a real-time tracking system in Michigan. It shows a 15 percent rise in suspected opioid overdose deaths since March, compared with the same time last year, and a 29% rise in first responders’ use of the rescue drug naloxone.

Released: 20-Oct-2020 2:25 PM EDT
From pills to powder: 1 in 3 high school seniors who misused prescription opioids later used heroin
University of Michigan

Nearly one-third of students who reported misusing prescription opioids as high school seniors between 1997 and 2000, but did not have a history of medical use, later used heroin by age 35, according to a University of Michigan study.

28-Sep-2020 11:50 AM EDT
Significant decline in prescription opioid abuse seen among Americans at last
American Society of Anesthesiologists (ASA)

Almost 20 years into the opioid epidemic, there finally is evidence of significant and continual decreases in the abuse of these risky pain medications, according to an analysis of national data being presented at the ANESTHESIOLOGY® 2020 annual meeting.

Released: 21-Sep-2020 5:05 AM EDT
College Students with Disabilities at Greater Risk for Substance Abuse
Rutgers University-New Brunswick

College students with physical and cognitive disabilities use illicit drugs more, and have a higher prevalence of drug use disorder, than their non-disabled peers, according to a Rutgers study.

Released: 17-Sep-2020 10:45 AM EDT
Preparing Future Clinicians to Intervene in Opioid Crisis
University of Pennsylvania School of Nursing

Opioid use disorder and overdose have reached unprecedented levels around the world. In the United States, remediation of pain is one of the most common reasons American adults seek healthcare. Therefore, it is vital that clinicians practicing in diverse roles and settings have a clinical understanding of pain and substance use disorders as well as knowledge about public health and opioid policy interventions.

14-Sep-2020 8:00 AM EDT
Potent Drug Supply Drop, Not U.S. Domestic Drug Policies, Likely Behind 2018’s Overdose Death Downturn
Health Sciences at the University of Pittsburgh

The slight decline in drug overdose deaths in 2018 coincides with Chinese regulations on the powerful opioid carfentanil, rather than the result of domestic U.S. efforts to curb the opioid epidemic, a University of Pittsburgh Graduate School of Public Health analysis revealed today.

Released: 15-Sep-2020 4:35 PM EDT
UTEP Partnership Receives Federal Grant to Combat Opioid Abuse in West Texas Counties
University of Texas at El Paso

The University of Texas at El Paso’s Minority AIDS Research Center (MARC) is the subrecipient of a $1 million implementation grant to target substance use disorders and opioid use disorders in five rural counties along the Texas-Mexico border.

Released: 15-Sep-2020 11:40 AM EDT
Abandoned Buildings, Fear of Calling Police Contribute to High Rate of Fatal Overdoses in Philadelphia, New Study Shows
American University

Abandoned Buildings, Fear of Calling Police Contribute to High Rate of Fatal Overdoses in Philadelphia, New Study Shows

Released: 14-Sep-2020 2:45 PM EDT
Virtual Reality Trains Public to Reverse Opioid Overdoses
University of Pennsylvania School of Nursing

The United States has seen a 200% increase in the rate of deaths by opioid overdose in the last 20 years. But many of these deaths were preventable. Naloxone, also called Narcan, is a prescription drug that reverses opioid overdoses, and in more than 40 states — including Pennsylvania — there is a standing order policy, which makes it available to anyone, without an individual prescription from a healthcare provider.

Released: 11-Sep-2020 10:10 AM EDT
University of Miami Miller School Researcher Wins NIH Avenir Award to Pursue Innovative Opioid Addiction Research
University of Miami Health System, Miller School of Medicine

Luis M. Tuesta, Ph.D., assistant professor in the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine, has been awarded the Avenir Award from the National Institute on Drug Abuse, part of the National Institutes of Health, to study the epigenetic mechanisms of microglial activation and their role in shaping the behavioral course of opioid use disorder.

Released: 8-Sep-2020 8:00 AM EDT
A pain reliever that alters perceptions of risk
Ohio State University

While acetaminophen is helping you deal with your headache, it may also be making you more willing to take risks, a new study suggests. People who took acetaminophen rated activities like “bungee jumping off a tall bridge” as less risky than people who took a placebo.

   
Released: 3-Sep-2020 7:05 PM EDT
UCLA Cannabis Research Initiative launches COVID-19 survey
University of California, Los Angeles (UCLA), Health Sciences

To better understand the effect of the COVID-19 pandemic on cannabis and CBD use, the UCLA Cannabis Research Initiative has launched the Cannabis, CBD and COVID Survey.

30-Aug-2020 11:00 AM EDT
Study Details How General Anesthetics And ‘Benzos’ Act on Receptors in The Brain
UT Southwestern Medical Center

As you drift into unconsciousness before a surgery, general anesthetic drugs flowing through your blood are putting you to sleep by binding mainly to a protein in the brain called the ɣ-aminobutyric acid type A (GABAA) receptor. Now UT Southwestern scientists have shown exactly how anesthetics attach to the GABAA receptor and alter its three-dimensional structure, and how the brain can tell the difference between anesthetics and the psychoactive drugs known as benzodiazepines – which also bind to the GABAA receptor. The findings were published online today in the journal Nature.

Released: 27-Aug-2020 4:05 PM EDT
Algorithm aims to alert consumers before they use illicit online pharmacies
Penn State Institute for Computational and Data Sciences

In a study, a team of Penn State researchers report that an algorithm they developed may be able to spot illicit online pharmacies that could be providing customers with substandard medications without their knowledge, among other potential problems.

   
19-Aug-2020 9:00 AM EDT
Clubs Closed? Study Finds Partygoers Turn to Virtual Raves and Happy Hours During Pandemic
New York University

People have traded in nightclubs and dance festivals for virtual raves and Zoom happy hours as a result of lockdowns during the COVID-19 pandemic—yet, many are using drugs in these socially distanced settings, according to a new study by researchers at NYU Grossman School of Medicine and the Center for Drug Use and HIV/HCV Research at NYU School of Global Public Health.

Released: 24-Aug-2020 9:00 PM EDT
New Remote Learning Program to Prevent Drug Abuse
National Health Promotion Associates

In the midst of the COVID-19 pandemic, opioid misuse and addiction continue to devastate communities around the US.

   
Released: 24-Aug-2020 12:50 PM EDT
COVID poses hardships for people with substance abuse problems
University of Michigan

FACULTY Q&ABoth fatal and nonfatal overdoses have increased this year compared to last, according to a recent report by the Overdose Data Mapping Application Program. And, anecdotal information suggests that compared to last year, people in recovery are relapsing at alarming rates.Faculty from the University of Michigan School of Nursing’s Center for the Study of Drugs, Alcohol, Smoking and Health discuss why the pandemic has hit people with substance abuse problems especially hard and the expanded role of virtual recovery programs.

Released: 24-Aug-2020 11:00 AM EDT
Clinical Utility of Hana® Orthopedic Table Highlighted in New Study: 97% of Direct Anterior Approach Hip Replacement Patients Needed Little to No Opioid Pain Medication After Surgery
Mizuho OSI

Mizuho OSI®, a leading manufacturer of specialty surgical tables and pressure injury abatement solutions would like to announce the publication of a new clinical study titled “23-hour Total Hip Replacement Requiring Only 3.5 Opioid Pills Through 6 Weeks: A Non-selected Prospective Consecutive One Year Cohort”, by Andrew Wickline MD, now appearing in the peer-reviewed Journal of Orthopedic Experience & Innovation (JournalOEI)

Released: 20-Aug-2020 11:25 AM EDT
IUPUI study looks at prevention strategy for substance use disorder
Indiana University

A recent study from IUPUI found risk factors for substance use disorder affect age groups differently and proposes a primary prevention strategy for substance use disorder that is individualized for people within defined age groups.

   


close
1.55232